Awards and Accolades

Finalist E&Y 2009 (Pacific Region)

iCo/JDRF partnership

Industry Leaders Involved with iCo

Company ran an almost 200 patient Phase 2 study (in conjunction with JDRF) with 5 FTEs, an enormous undertaking

Former iCo Board Members/Alumni

Current and Previous Deals

Ionis Pharmaceuticals, Cambridge Antibody Technology (CAT), Bill & Melinda Gates Foundation and Juvenile Diabetes Research Foundation (JDRF)